Regulus Therapeutics Inc (NASDAQ:RGLS) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Garry E. Menzel Other companies: Adaptimmune Therapeutics PLC (Non-Executive Director · Since at least Jun 1, 2023); Stoke Therapeutics, Inc. (Director · Since at least Aug 13, 2020); Black Diamond Therapeutics, Inc. (Operating Partner, GHO Capital Partners LLP · Since at least Jan 29, 2020); Tcr2 Therapeutics Inc (President and CEO, Director · Feb 13, 2019 – Jun 1, 2023 · Past); DaVita Inc. (Senior Vice President, Finance · Sep 9, 2013 – Sep 9, 2013 · Past) | COO & Executive VP, Finance · Oct 4, 2012 – Dec 11, 2012 · Past |
| Stelios Papadopoulos Other companies: Ovid Therapeutics Inc. (Director, Member of the Audit and Compensation Committees · Since at least Mar 1, 2025); Exelixis, Inc. (Chair of the Board, Exelixis, Inc. · Since at least May 24, 2012); BG Medicine Inc (Director · Since at least Nov 9, 2011); Eucrates Biomedical Acquisition Corp. (Director · Oct 23, 2020 – Nov 24, 2020 · Past); Biogen Inc. (Director · Jun 8, 2012 – Jun 15, 2022 · Past) | Director · Since at least Oct 4, 2012 |
| Mark Foletta Other companies: Enanta Pharmaceuticals, Inc. (Director · Since at least Jun 29, 2020); AMN Healthcare Services Inc (Director · Since at least Nov 27, 2017); DexCom, Inc. (Director · Since at least Nov 27, 2017); Tocagen Inc (EVP & Chief Financial Officer · Dec 8, 2017 – Oct 4, 2019 · Past) | Director · Dec 4, 2017 – Dec 4, 2017 · Past |
| Jason Raleigh Nunn Other companies: Addex Therapeutics Ltd (Director · Since at least Mar 18, 2026); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Trevena, Inc. (Director · May 16, 2019 – Jun 13, 2024 · Past) | Director · Since at least Jun 6, 2019 |
| Neil Gibson Other companies: Instil Bio, Inc. (Board Member · Since at least Mar 18, 2021); Shattuck Labs, Inc. (Director · Since at least Oct 8, 2020); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Jun 1, 2023 · Past) | Chief Scientific Officer · Oct 4, 2012 – Jan 28, 2015 · Past |
| Pascale Witz Other companies: Revvity, Inc. (Director · Since at least Oct 27, 2017); Tesaro Inc (Director · May 10, 2018 – Jan 22, 2019 · Past); Horizon Pharma PLC (Director · Aug 2, 2017 – Aug 2, 2018 · Past) | Director · Since at least Jun 1, 2017 |
| Daniel R Chevallard Other companies: LENZ Therapeutics, Inc. (Chief Financial Officer · Since at least Mar 21, 2024); Viracta Therapeutics Inc (CFO and COO · Mar 26, 2021 – Mar 12, 2024 · Past) | Chief Financial Officer · May 4, 2017 – Jul 1, 2019 · Past |
| David Baltimore Other companies: Amgen Inc. (Director · Mar 30, 2016 – Apr 27, 2018 · Past); Immune Design Corp (Director · Jan 4, 2016 – Apr 2, 2019 · Past) | Director · Since at least Jun 2, 2016 |
| Simos Simeonidis Other companies: Sarissa Capital Acquisition Corp (Senior Managing Director · Oct 20, 2020 – Oct 20, 2020 · Past) | Director · Jun 6, 2019 – Jun 9, 2022 · Past |
| Timothy Michael Wright Other companies: Schrodinger, Inc. (Director · Feb 5, 2020 – Feb 10, 2020 · Past) | Chief R & D Officer · Dec 4, 2017 – Feb 5, 2019 · Past |
| Alice Shih-hou Huang | Director · Since at least Jan 6, 2021 |
| Christopher Ray Aker | Sr. VP & General Counsel · Since at least Jan 1, 2019 |
| Denis Drygin | Chief Scientific Officer · Aug 3, 2020 – Mar 1, 2022 · Past |
| Hugh Rosen | Director · Since at least Jun 2, 2016 |